[RPRX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
29-Dec-2016
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -2.67%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Annual Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 2,289,463 2,122,000 1,814,254 1,794,894 1,597,930 1,877,410 1,652,420 5.57%
PBT 1,241,201 1,702,000 2,461,419 1,517,855 1,343,180 761,895 758,708 8.54%
Tax 762,447 1,147,000 349,333 433,365 542,655 195,988 177,282 27.49%
NP 478,754 495,198 2,348,535 1,377,729 1,210,025 565,907 581,426 -3.18%
Tax Rate -61.43% -67.39% -14.19% -28.55% -40.40% -25.72% -23.37% -
Total Cost 1,810,709 1,626,802 -534,281 417,165 387,905 1,311,503 1,070,994 9.13%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 20.91 23.34 129.45 76.76 75.72 30.14 35.19 -8.30%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS 1.15 1.32 6.42 3.89 3.42 0.93 0.96 3.05%
EPS Diluted 1.15 1.32 6.42 3.89 3.42 0.93 0.96 3.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.